Stryker Corporation (SYK)

Market Cap	126.06B -11.5%
Revenue (ttm)	25.12B +11.2%
Net Income	3.25B +8.5%
EPS	8.40 +8.2%
Shares Out	382.69M
PE Ratio	39.21
Forward PE	22.00
Dividend	$3.52 (1.07%)
Ex-Dividend Date	Mar 31, 2026

Volume	1,657,169
Open	329.28
Previous Close	328.59
Day's Range	326.55 - 331.57
52-Week Range	319.32 - 404.87
Beta	0.93
Analysts	Buy
Price Target	429.42 (+30.36%)
Earnings Date	Apr 30, 2026

About SYK

Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally inv...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1941
• Employees: 56,000
• Stock Exchange: NYSE
• Ticker Symbol: SYK
• Website: https://www.stryker.com

Financial Performance

In 2025, Stryker's revenue was $25.12 billion, an increase of 11.16% compared to the previous year's $22.60 billion. Earnings were $3.25 billion, an increase of 8.45%.

Analyst Summary

According to 12 analysts, the average rating for SYK stock is "Buy." The 12-month stock price target is $429.42, which is an increase of 30.36% from the latest price.

Price Target

$429.42

(30.36% upside)

Analyst Consensus: Buy